One important characteristic of IL-6 is the persistent activation in the whole process of inflammatory bowel disease and CRC, while the upregulations of other cytokines like TGF-β1, IL-10, and IL-23 only show up primarily during CRC development [38]. This evidence concerns the gene IL6 and colorectal carcinoma.